Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pediatrix Medical GroupFRA:PDC -0.88%29 Intrinsic Value: Projected FCF is €23.71 as of Sep. 12, 2026. GuruFocus rates FRA:PDC with a GF Score™ of 29/100 and a GF Value™ of €11.59 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 346 Healthcare Providers & Services companies, Pediatrix Medical Group ranks better than 55.2% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for Pediatrix Medical Group's Intrinsic Value: Projected FCF or its related term are showing as below:
FRA:PDC'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.22 Med: 0.52 Max: 0.95
Current: 0.95
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Pediatrix Medical Group was 0.95. The lowest was 0.22. And the median was 0.52.
FRA:PDC's Price-to-Projected-FCF is ranked better than 55.2% of 346
companies
in the Healthcare Providers & Services industry
Industry Median: 1.055
vs FRA:PDC: 0.95
Pediatrix Medical Group (FRA:PDC) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Pediatrix Medical Group's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
22.60
/
24.932890405787
=
0.91
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group Intrinsic Value: Projected FCF Related Terms
Pediatrix Medical Group Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Pediatrix Medical Group's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group Intrinsic Value: Projected FCF Chart
FRA:PDC vs ADUS, GRDN, ASTH: Intrinsic Value: Projected FCF Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Price-to-Projected-FCF falls into.
Pediatrix Medical Group Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of €23.71 mean?
Pediatrix Medical Group (FRA:PDC) has a Intrinsic Value: Projected FCF of €23.71 as of Sep. 12, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Pediatrix Medical Group and its competitors. According to the industry distribution chart, Pediatrix Medical Group ranks #155 out of 346 companies in the Healthcare Providers & Services industry, placing it in the top 44.8%.
Is Pediatrix Medical Group's Intrinsic Value: Projected FCF too high?
Pediatrix Medical Group's current Intrinsic Value: Projected FCF is €23.71. Based on the distribution chart, Pediatrix Medical Group ranks #155 out of 346 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Pediatrix Medical Group has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Intrinsic Value: Projected FCF compare to ADUS and GRDN?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #155 out of 346 companies for Intrinsic Value: Projected FCF. This puts Pediatrix Medical Group in the upper half of its industry. The industry median Intrinsic Value: Projected FCF is 1.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.06, based on 346 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current Intrinsic Value: Projected FCF is €23.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.59, compared to a current price of €22.60 — trading 95% above its estimated fair value. The current Intrinsic Value: Projected FCF is €23.71. Pediatrix Medical Group's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Intrinsic Value: Projected FCF is €23.71 as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €22.60 is trading 95% above its estimated GF Value™ of €11.59.
GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.
Key valuation signals for FRA:PDC:
Intrinsic Value: Projected FCF: €23.71
GF Value™: €11.59 vs. price of €22.60 (95% above fair value)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
29GF Score
Get the complete analysis for FRA:PDC
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
